InvestorsHub Logo
Followers 6
Posts 447
Boards Moderated 0
Alias Born 12/28/2013

Re: None

Thursday, 08/20/2015 9:09:33 AM

Thursday, August 20, 2015 9:09:33 AM

Post# of 3108
GREAT POINT PARTNERS Top 10 13F Positions in Q2 2015
http://www.octafinance.com/great-point-partners-top-10-13f-positions-in-q2-2015/165879/

Important Position Changes

Top 10 Q2 2015 New Positions: Five Prime Therapeutics Inc (FPRX), Synergy Pharmaceuticals Del (SGYP), Paratek Pharmaceuticals Inc (PRTK), Relypsa Inc (RLYP), Antares Pharma Inc (ATRS), Caladrius Biosciences Inc, Zogenix Inc (ZGNX), Biodel Inc (BIOD), Sagent Pharmaceuticals Inc (SGNT) and Xenoport Inc (XNPT).

it's possible to download the full 13F form in CSV
Download the full 13F form in CSV: Q2-2015-Great-Point-Partners-Llc-Jeffrey-Jay-And-David-Kroin-13F-Portfolio-Stock-Holdings.csv

13 CALADRIUS BIOSCIENCES INC,4630,2476120,1.80,0.00,,2476120,New

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LSTA News